Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies. | Explor Target Antitumor Ther | 2025 | 40061138 | PubTator, text mining | PubMed |
| Structure-Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein-Targeting PROTACs. | Angew Chem Int Ed Engl | 2025 | 40000409 | PubTator, text mining | PubMed |
| Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Anticancer Res | 2025 | 39890181 | PubTator, text mining | PubMed |
| Cytologic, histologic, and clinical correlation of minor mutations in pancreatic cysts. | Cancer Cytopathol | 2025 | 39865498 | PubTator, text mining | PubMed |
| [NTRK gene fusion and molecular pathological characteristics of mismatch repair deficient colorectal cancer]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 39863528 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma. | Curr Oncol | 2025 | 39851951 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer. | Cancer Sci | 2025 | 39797621 | PubTator, text mining | PubMed |
| Structural insights into the LGR4-RSPO2-ZNRF3 complexes regulating WNT/β-catenin signaling. | Nat Commun | 2025 | 39753551 | PubTator, text mining | PubMed |
| Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis. | Mol Cancer Res | 2025 | 39751654 | PubTator, text mining | PubMed |
| Molecular and immunohistochemical markers in appendiceal mucinous neoplasms: A systematic review and comparative analysis with ovarian mucinous neoplasms and colorectal adenocarcinoma. | Histol Histopathol | 2025 | 39743929 | PubTator, text mining | PubMed |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. | Int J Cancer | 2025 | 39740007 | PubTator, text mining | PubMed |
| Stem Cell Markers LGR5, LGR4 and Their Immediate Signalling Partners are Dysregulated in Preeclampsia. | Stem Cell Rev Rep | 2025 | 39688759 | PubTator, text mining | PubMed |
| Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels. | Oncogene | 2025 | 39674817 | PubTator, text mining | PubMed |
| Gender-based differences in the efficacy of anti-EGFR/BRAF/MEK targeted therapy in patients with BRAF-mutated metastatic colorectal cancer. | Semin Oncol | 2025 | 39627078 | PubTator, text mining | PubMed |
| Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer. | Oncologist | 2025 | 39531357 | PubTator, text mining | PubMed |
| Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. | Prostate Cancer Prostatic Dis | 2025 | 39019980 | PubTator, text mining | PubMed |
| Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. | Eur Urol Oncol | 2025 | 38862340 | PubTator, text mining | PubMed |
| Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer. | Mol Cancer | 2024 | 39587554 | PubTator, text mining | PubMed |
| RNF43 and ZNRF3: Versatile regulators at the membrane and their role in cancer. | Biochim Biophys Acta Rev Cancer | 2024 | 39551397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=6